Cargando…
TORC2: a novel target for treating age-associated memory impairment
Memory decline is one of the greatest health threats of the twenty-first century. Because of the widespread increase in life expectancy, 20 percent of the global population will be over 60 in 2050 and the problems caused by age-related memory loss will be dramatically aggravated. However, the molecu...
Autores principales: | Johnson, Jennifer L., Huang, Wei, Roman, Gregg, Costa-Mattioli, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614817/ https://www.ncbi.nlm.nih.gov/pubmed/26489398 http://dx.doi.org/10.1038/srep15193 |
Ejemplares similares
-
mTORC2 controls actin polymerization required for consolidation of long-term memory
por: Huang, Wei, et al.
Publicado: (2013) -
Regulation of filial imprinting and structural plasticity by mTORC1 in newborn chickens
por: Batista, Gervasio, et al.
Publicado: (2018) -
mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors
por: Zhu, Ping Jun, et al.
Publicado: (2018) -
Targeted suppression of mTORC2 reduces seizures across models of epilepsy
por: Okoh, James, et al.
Publicado: (2023) -
Intrahippocampal glutamine administration inhibits mTORC1 signaling and impairs long-term memory
por: Rozas, Natalia S., et al.
Publicado: (2015)